Trial Information
Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes in Patients with Non-Small Cell Lung Cancer Not Previously Treated for Metastatic Disease to Determine Eligibility for a Biomarker Selected Clinical Trial (KEAPSAKE Trial)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724